Tanfac Industries Ltd
Incorporated in 1972, Tanfac Industries Ltd is amongst the leading producers of Hydrofluoric Acid and its derivatives.
- Market Cap ₹ 7,565 Cr.
- Current Price ₹ 3,497
- High / Low ₹ 3,648 / 1,633
- Stock P/E 109
- Book Value ₹ 341
- Dividend Yield 0.13 %
- ROCE 23.9 %
- ROE 20.3 %
- Face Value ₹ 5.00
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.1%
- Company's median sales growth is 22.4% of last 10 years
- Company's working capital requirements have reduced from 51.6 days to 34.2 days
Cons
- Stock is trading at 10.2 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Part of BSE Commodities BSE 1000
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 | 133 | 126 | 162 | 222 | 165 | 148 | 320 | 375 | 378 | 557 | 711 | 784 | |
| Sales growth | +2% | +11% | -5% | +28% | +37% | -26% | -10% | +116% | +17% | +1% | +47% | +28% | +13% |
| 112 | 125 | 112 | 141 | 169 | 138 | 115 | 244 | 299 | 306 | 426 | 597 | 672 | |
| Operating Profit | 8 | 9 | 14 | 21 | 53 | 27 | 33 | 76 | 76 | 72 | 131 | 114 | 112 |
| OPM % | 7% | 7% | 11% | 13% | 24% | 16% | 22% | 24% | 20% | 19% | 24% | 16% | 14% |
| 1 | 4 | 1 | 0 | 1 | 1 | 1 | 3 | 8 | 7 | 3 | 2 | 5 | |
| Interest | 10 | 8 | 7 | 7 | 4 | 2 | 1 | 2 | 2 | 2 | 5 | 6 | 5 |
| Depreciation | 6 | 5 | 5 | 5 | 8 | 5 | 8 | 6 | 6 | 7 | 10 | 17 | 19 |
| Profit before tax | -7 | 0 | 3 | 10 | 42 | 22 | 25 | 72 | 75 | 70 | 119 | 93 | 93 |
| Tax % | -20% | -8% | 0% | 1% | 14% | 22% | 30% | 26% | 26% | 25% | 26% | 24% | |
| -5 | 0 | 3 | 10 | 36 | 17 | 17 | 53 | 56 | 52 | 88 | 70 | 69 | |
| EPS in Rs | -2.64 | 0.20 | 1.64 | 4.84 | 17.98 | 8.48 | 8.74 | 26.64 | 28.06 | 26.24 | 44.08 | 35.16 | 33.56 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 17% | 12% | 13% | 10% | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 37% |
| 3 Years: | 24% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 37% |
| 5 Years: | 32% |
| 3 Years: | 8% |
| TTM: | -26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 65% |
| 5 Years: | 68% |
| 3 Years: | 49% |
| 1 Year: | 83% |
| Return on Equity | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 29% |
| 3 Years: | 25% |
| Last Year: | 20% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 |
| Reserves | -10 | -10 | -7 | 3 | 38 | 55 | 73 | 124 | 174 | 220 | 302 | 363 | 726 |
| 69 | 61 | 54 | 43 | 12 | 0 | 0 | 0 | 0 | 0 | 41 | 93 | 136 | |
| 26 | 30 | 20 | 29 | 48 | 24 | 37 | 49 | 68 | 71 | 73 | 62 | 133 | |
| Total Liabilities | 95 | 91 | 77 | 86 | 107 | 89 | 120 | 182 | 252 | 301 | 426 | 528 | 1,006 |
| 53 | 49 | 45 | 41 | 34 | 33 | 40 | 40 | 55 | 61 | 168 | 212 | 237 | |
| CWIP | 0 | 0 | 0 | 0 | 1 | 6 | 3 | 12 | 6 | 29 | 8 | 29 | 153 |
| Investments | 0 | 0 | 1 | 1 | 1 | 1 | 23 | 42 | 67 | 67 | 9 | 19 | 60 |
| 42 | 42 | 31 | 44 | 71 | 49 | 55 | 88 | 124 | 145 | 242 | 269 | 556 | |
| Total Assets | 95 | 91 | 77 | 86 | 107 | 89 | 120 | 182 | 252 | 301 | 426 | 528 | 1,006 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 | 16 | 16 | 17 | 37 | 22 | 37 | 44 | 43 | 34 | 33 | 43 | |
| 0 | -1 | -1 | -1 | -3 | -9 | -34 | -35 | -40 | -30 | -42 | -91 | |
| -10 | -15 | -15 | -17 | -34 | -12 | -1 | -5 | -6 | -7 | 32 | 38 | |
| Net Cash Flow | -0 | -0 | 0 | -0 | 0 | -0 | 2 | 5 | -3 | -3 | 23 | -9 |
| Free Cash Flow | 9 | 15 | 15 | 17 | 35 | 11 | 29 | 29 | 28 | -2 | -64 | -39 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 111% | 183% | 105% | 73% | 83% | 99% | 121% | 82% | 79% | 73% | 47% | 56% |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 52 | 54 | 46 | 44 | 38 | 40 | 40 | 28 | 49 | 59 | 65 | 57 |
| Inventory Days | 106 | 82 | 66 | 75 | 107 | 75 | 134 | 91 | 89 | 100 | 112 | 79 |
| Days Payable | 89 | 97 | 69 | 74 | 90 | 47 | 142 | 76 | 78 | 77 | 48 | 21 |
| Cash Conversion Cycle | 68 | 39 | 42 | 45 | 54 | 67 | 31 | 43 | 60 | 82 | 129 | 115 |
| Working Capital Days | -150 | -124 | -109 | -53 | 35 | 65 | 36 | 33 | 46 | 59 | 62 | 34 |
| ROCE % | 4% | 7% | 18% | 29% | 78% | 37% | 35% | 67% | 48% | 33% | 42% | 24% |
Insights
In beta| Mar 2017 | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Hydrofluoric Acid Installed Capacity MTPA |
|
||||
| Sulphuric Acid Installed Capacity MTPA |
|||||
| Specialty Fluorides Installed Capacity MTPA |
|||||
| Total Manufacturing Capacity MTPA |
|||||
| Hydrofluoric Acid Capacity Utilization % |
|||||
| Long-term Order Book Rs Crore |
|||||
| Solar Grade DHF Installed Capacity MTPA |
|||||
| Specialty Fluorides Capacity Utilization % |
|||||
| Sulphuric Acid Capacity Utilization % |
|||||
Extracted by Screener AI
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Audio recording of Q2 and H1 FY2026-27 earnings conference call made available on website.
-
Statement Of Deviation & Variation
- QIP ₹249.99 crore and preferential allotment ₹99.40 crore used with no deviation.
- Announcement under Regulation 30 (LODR)-Investor Presentation
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
- TANFAC reported Q2 FY27 revenue ₹234.3 crore, completed ₹100 crore preferential issue, and raised DHF capacity 25%.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Concalls
-
Nov 2026PPT REC
-
Aug 2026Transcript PPT REC
-
May 2026Transcript PPT REC
-
Feb 2026PPT
Product Portfolio:[1]
The company manufactures inorganic
fluorine-based chemicals like Anhydrous Hydrofluoric acid, Sulphuric Acid, Oleum, Aluminum Fluoride, Potassium Fluoride, Potassium Bifluoride, Boron Trifluoride Complexes, Calcium Sulphate (Gypsum), Isobutyl Acetophenone, Acetic Acid,
Peracetic Acid and Poly Aluminum
Chloride, etc.